By Xavior Robinson, Senior Manager, Health Care Access, NASTAD
March 23 marked the fourth anniversary of the Affordable Care Act (ACA). While it is undeniable that the ACA’s inaugural open enrollment period has had its share of challenges, it is important to recognize that the movement to ensure that all Americans have equitable access to health care transcends the technology failures of HealthCare.gov. Over the past four years, state HIV/AIDS programs have worked to adapt and innovate to meet needs of people living with HIV and co-occurring conditions in our evolving health care landscape. Through the use of innovative solutions (see Raising the Bars), support from colleagues and staff, and an enduring commitment to the broader public health imperative presented by HIV, state AIDS directors have leveraged the ACA to achieve remarkable results, including: Continue reading
By Amanda Bowes, Associate, Health Care Access and Viral Hepatitis, NASTAD
Today, the National Alliance of State and Territorial AIDS Directors (NASTAD) released key findings of the 2014 National ADAP Monitoring Project Annual Report. The National ADAP Monitoring Project is NASTAD’s long-standing effort to document new developments and challenges facing AIDS Drug Assistance Programs (ADAPs), assessing key trends over time and providing the latest available data on the status of ADAPs. For the last 19 years, NASTAD has provided comprehensive analysis about ADAPs through The Report.
The Report provides an overview of the status of ADAPs as they prepared for full implementation of the Affordable Care Act (ACA). Continue reading
By Amy Killelea, Associate Director, Health Care Access, NASTAD
Insurers in two states – Blue Cross and Blue Shield in Louisiana and North Dakota – have prohibited the acceptance of premium payments from the Ryan White Program/AIDS Drug Assistance Program (ADAP) on behalf of eligible low-income clients. These policies risk leaving hundreds of low-income people living with HIV unable to access Qualified Health Plan coverage through the Affordable Care Act (ACA) and have prompted a swift federal and state advocacy response.
After Five Years, ADAP Waiting Lists Have Been Eliminated; Unmet Need and Funding Uncertainties Require Continued Commitment
FOR IMMEDIATE RELEASE
Contact: Murray Penner
November 25, 2013, Washington, DC – According to NASTAD’s latest ADAP Watch, released today, there are no individuals on AIDS Drug Assistance Program (ADAP) waiting lists in the United States. This represents a significant milestone as there have been individuals on ADAP waiting lists since January 2008. The last state to have a waiting list, South Dakota, was able to transition the remaining 11 individuals on their waiting list into their ADAP program on November 21. Earlier this month, Alabama and Idaho eliminated their waiting lists and lifted their enrollment caps. Continue reading